On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Award-Winning Deltec Bank & Trust Ltd. Provides Financial Expertise to Global Investment Community in Navigating Pandemic Era

  • Deltec recently released investment research concerning COVID-19-related U.S. stimulus package
  • Company’s combined expertise comprises more than 150 professionals, including private bankers, certified public accountants, investment advisors, lawyers, trust officers
  • Deltec recently recognized as ‘Best Private Bank in the Caribbean 2020’ by Global Banking and Finance Review

As a leading financial hub for the global investment, finance and entrepreneur community, Deltec Bank & Trust offers specialized financial solutions and institutional expertise with the primary goal of creating opportunities for its clients to enhance their wealth. As part of its service offerings, the company recently released a special report (http://ibn.fm/7Ig6O) outlining details of the U.S. government’s $2.2 trillion Coronavirus Aid, Relief, and Economic Security (“CARES”) stimulus package. The timely piece includes commentary concerning the potential effects to US personal incomes should the unemployment insurance benefits be allowed to expire at the end of the month without extension.

Besides offering specialized services that span private, corporate and merchant banking, Deltec moves beyond its core set of services by providing specialized research reports published periodically for the benefit of its clients.

Forming part of Deltec’s global financial hub is the collective experience of more than 150 professionals gleaned from a wide array of backgrounds, including private bankers, certified public accountants, investment advisors, lawyers and trust officers. With the power of their combined experience from some of the world’s largest and most prestigious financial institutions, the professionals at Deltec provide unparalleled expertise in working with complex multi-jurisdictional entities in addition to individuals and families aiming to protect their wealth. The company’s assets under management, administration and custody have risen substantially as a result of the purchase of Société Generale’s private banking business in The Bahamas, growing to over $12 billion as of late 2019 (http://ibn.fm/lZTrN).

Recognized periodically for its outstanding performance and achievements, Deltec recently won the ‘Best Private Bank in the Caribbean 2020’ award for a second time from the Global Banking and Finance Review (http://ibn.fm/s724h). Besides being recognized internationally for strong client relations and highly personalized innovative products, Deltec maintains a strong position at the forefront of the digital banking and fintech revolution with its annual conference focused on disruptive technologies within the financial services industry (http://ibn.fm/BdQSA).

Founded in 1959, Deltec Bank & Trust Ltd. is the flagship company of the Deltec International Group, a diversified independent financial services organization that provides a wide range of financial services that include investment management and research, fund administration, merchant banking, corporate advisory, digital asset solutions and global insurance. Besides providing top-tier services for their diverse range of clientele, Deltec also actively engages with the local community in The Bahamas through its Deltec Initiatives Foundation that aims to empower youth in driving forward positive social impact through the power of the arts, entrepreneurship and education.

For more information, visit the company’s website at www.DeltecBank.com.

NOTE TO INVESTORS: The latest news and updates relating to Deltec are available in the company’s newsroom at http://ibn.fm/Deltec

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.